...a) Why does JJM want to switch Pepcid to OTC when the patent is good for another six years? What would be the optimal time to switch and factors that affect this decision? Would it be the same for all competitors? Firstly, the OTC (over-the-counter) market growth is a huge attraction to pharmaceutical companies, great potential profit can be expected from OTC market. Fierce competition is not avoidable after the patent expires, which may drive down the profit margin. However, some examples, such as Listerine, indicated that OTC product can maintain in the market for a much longer time, because consumers have the tendency to self-diagnose their common ailments, and obtain a drug without prescription. Secondly, Pepcid is a safe drug, and its indication is a common chronic problem in public that is relatively easy to self-diagnose and self-treat. By making such a drug an OTC product, the company can gain access to a larger consumer base and thus gain more profit. Pepcid as a prescription drug has already gained its market as a brand name drug. This creates a demand for the general public for OTC version of Pepcid. Additionally, usually FDA takes several years to process the approval of a prescription-to-OTC switch. Before the patent expires, JJM can take the advantage of patent protection and enter the OTC without competition and thus occupy a larger consumer market earlier. Factors include indication, drug safety, and brand awareness. The indication has to be a common and...
Words: 1071 - Pages: 5
...Autumn Internship Report, Sep – Nov 2010 Research related work Research report preparation on the Nutraceuticals Sector Objective – Nutraceuticals are substances that offer nutrition beyond standard diet and include both fortified foods and beverages marketed by FMCG companies as well as dietary supplements that are mainly sold by pharmaceutical companies. Nutraceuticals is an emerging sector in India, and o3 Capital is looking at active participation in this space going forward. o3 Capital has a strong focus on research and such sector reports are often used to showcase the company’s capabilities to both potential client as well as investors. The main objective of this assignment was to prepare a comprehensive report on the sector that can eventually be used as part of client pitches and investor documents. The project also involved preparing brief profiles of key players in the sector to facilitate future business development activities in this space, and compilation of major global transactions in order to analyse transaction metrics and potential Scope – Following was the broad scope of the report 1. Overview of the global nutraceuticals market covering 1.1. Market Size and Growth 1.2. Key Markets 2. Detailed section on the Indian Nutraceuticals market covering 2.1. Market Size and Growth 2.2. Key Segments 2.3. Drivers 2.4. Challenges 2.5. Emerging product categories 3. Comparables Analysis and Investment Activity 3.1. Global Comparables 3.2. Global M&A Transaction...
Words: 9552 - Pages: 39
...“Practice of Pharmacy”*DOES NOT INCLUDE: other providers dispensing drugs (including nurses), hospitals engaged in compounding/ dispensing, etc | a. the interpretation, evaluation, and implementation of a medical order, b. the dispensing of drugs and devices, c. drug product selection, d. the administration of drugs or devices e. drug utilization review, f. patient counseling, g. the provision of pharmaceutical care, and h. the responsibility for compounding and labeling of dispensed or repackaged drugs and devices, proper and safe storage of drugs and devices, and maintenance of proper records. | “active practice of pharmacy” | the performance of the functions set out in this section by a pharmacist as his or her principal or ordinary occupation | “pharmaceutical care”Note: CAN enter into practice agreement | the provision of drug therapy for the purpose of achieving therapeutic outcomes that improve a patient's quality of life, including include a. the cure of disease b. the elimination or reduction of a patient's symptomatology c. the arrest or slowing of a disease process d. the prevention of a disease or symptomatology | Equipment and Reference material requirements for operating a pharmacy | * Not very specific anymore * Up to judgment of pharmacist based on what they will be doing in the pharmacy * References must be up to date, in either printed or electronic form, and available...
Words: 7455 - Pages: 30
...History • Personal and Social History • Review of Systems • Physical Exam • QuEST/SCHOLAR-MAC Introduction The patient interview is the primary way of obtaining comprehensive information about the patient in order to provide effective patient-centered care, and the medication history component is the pharmacist’s expertise. A methodological approach is used to obtain information from the patient, usually starting with determining the patient’s chief complaint, also known as the reason for the healthcare visit, and then 2 Chapter 1 / The Patient Interview delving further into an exploration of the patient’s specific complaint and problem. A comprehensive patient interview includes inquiring about the patient’s medical, medication, social, personal, and family history, as well as a thorough review of systems and possibly a physical examination. The medication history is the part of the patient interview that provides the pharmacist the opportunity to utilize his or her expertise by precisely collecting each component of the medication history (however, a medication history may also be...
Words: 14665 - Pages: 59
...its coveted Food and Drug Administration (FDA) approval. CSP was an international healthcare company with over $25 billion in sales in 2007. The company, based in Cambridge, Massachusetts, focused on developing, manufacturing, and marketing products that treated metabolic disorders, gastrointestinal diseases, and immune deficiencies, as well as other chronic and acute medical conditions. Metabical was part of a strategic initiative that would allow CSP to enter the $3.74 billion market for weight-control products in the United States.1 tC CSP’s chief marketing officer, Bernard Long, said of the new product: No Metabical is revolutionary. It will be the first and only prescription drug to receive FDA approval to meet the needs of the millions of individuals struggling with moderate weight-loss goals. Previous prescription weight-loss drugs had negative side effects that, in the agency’s judgment, outweighed the benefits provided to individuals who were not considered obese. Metabical will be approved for use by those looking to shed between 10 to 30 pounds. Initial reviews from the medical community indicate a strong endorsement of Metabical. Our product will offer moderately overweight adults a medically proven, effective method to reach a desirable weight and improve their overall health. 1 According to Mintel Interational Group’s Weight Control Products - US - March 2007 Report, total U.S. retail sales of weight control products in 2007 were estimated...
Words: 4511 - Pages: 19
...Costco Pharmacy POM Audit Team 7 Executive Summary Design of Goods and Services- Costco can be seen to be in their maturity stages of their life. Therefore, it is recommended for Costco to expand its Pharmacy department by at least 50%. Process Design-Costco processes prescriptions and provides the prescribed drugs to customers. For each prescription, pharmacists carefully review the dosage along with other drugs you may be taking in order to prevent any chance of medications interacting with each other. They also ensure you do not receive any medication which could result in an allergic reaction. It is recommended to introduce E-prescribing in the near future as it would reduce the duration for each prescription process. Layout-The Costco Pharmacy Layout can be defined as a Retail Layout. The main objective of a retail layout is to maximize profitability per square foot of floor space. However further research will need to be conducted to make a recommendation Capacity- Even though the pharmacy department is not operating at 100% efficiency, it is still using and managing their facilities effectively, operating at 72% efficiency on a daily basis. However, future capacity planning is required as the efficiency capacity is increasing as population grows. Productivity- The labor productivity is currently5 units per labor hours while the multifactor productivity is 0.040 units per dollar. After auditing Costco’s productivity it was found that Costco should aim to increase...
Words: 13869 - Pages: 56
...was African-American and her mother is Hispanic. She has 4 brothers and 2 sisters. She is married and lives with her husband and his son in their private home. She has two children, fathered by her ex-husband, who are now in custody of LS’s mother. Her children were taken away from her, by the court, due to her abuse of drugs and alcohol. LS stated that her father abused alcohol and that all of her brothers and sisters abused drugs and were diagnosed with bipolar disorder. LS stated that she started noticing symptoms of what she thought was depression 6 years ago but was diagnosed with bipolar disorder in 2005. Her chart stated that she has had an 11 year history of bipolar disorder. Presenting Problem: LS stated that she had not been taking her medications for four days because her husband forgot to pick up her medications from the pharmacy. However, her chart stated that she was off of her medications for 14 days. She was arrested at a K-Mart store for shoplifting. She stated that she wanted to return the shoes she was wearing because they were too small. Instead of going to customer service, she exchanged her old shoes for new ones, and left the old shoes on the rack, without notifying any of the staff. As she was about to walk out of the store, security stopped her and called the police....
Words: 7435 - Pages: 30
... Content I. Company Overview 2 II. Securities Details 5 III. Financial Analysis 8 IV. Corporate Governance 12 V. References 18 Group: Group Member: Company Overview |Business Description: | |(Please provide underwriting analysis of business operations, existing product portfolio, services, etc.) | |The company is a distributor of pharmaceutical and medical products in the People's Republic of China (PRC), including prescription and | |over-the-counter drugs, Chinese herbs, traditional Chinese medicines made from Chinese herbs, nutritional supplements, dietary | |supplements, and medical instruments. The Company is also engaged in research and development with the aim of creating new pharmaceutical| |products and intellectual property that it may sell in the future. | |Strategy, Market and Dependencies: | |(Please provide analysis of the Company’s strategy strengths and weaknesses - business model, market share, and competition. What were | |the Company’s threats and opportunities in the last 12 months, outlook for the future...
Words: 3593 - Pages: 15
...Polypharmacy in the Elderly Courtney Lopez Western Governors University Polypharmacy in the Elderly I. Introduction a. Audience hook: John, an 85 year old man is admitted into the emergency room with a heart rate of 40, and complaints of dizziness and weakness for several days. Nancy RN is the nurse taking care of John when he is brought in. Upon reviewing Johns’ medications, Nancy is aware that there are two prescriptions for the same beta blocker each with a different dose and frequency, among six other prescriptions. When questioned about his medications, John states "he takes two different medications for his heart with some other pills, but doesn’t know the name of the medication or the dose." John is diagnosed with a beta blocker overdose. After four days in the ICU, John is feeling much better now, with normal vital signs and a better knowledge of his medications, and will be transferred to a telemetry floor for continued care. b. Thesis statement: Polypharmacy in the elderly population can be reduced by early discharge education in the inpatient setting, along with the use of drug combinations or extended release medications to lower the frequency, amounts, and financial burden incurred by this population. c. Main points: 1. Multiple dosing changes and frequency of medications can cause confusion, adverse reactions, and noncompliance. 2. Education during hospitalization can decrease recurrence of repeat hospitalization. II. Polypharmacy...
Words: 1619 - Pages: 7
...Orthopedic aftercare NEC, Depressive disorder, Chronic pain NEC, Hypertension NEC, Insomnia NOS, Alcohol cirrhosis liver. Stump is still draining, swollen (2/19) Code Status: I (full) Reason for admission to Facility: Rehab for AKA (Above the Knee Amputation) Past Medical History (from chart):Chronic pain, traumatic blindness right eye, COPD, Asthma, restless leg syndrome, obstructive sleep apnea, AFIB, sick sinus syndrome, HTN, venous insufficiency, cirrhosis(liver),esophageal varices with bleed. Admitting/ Attending Physician: Dr Andreas/ Burnside Diet ordered:Regular Activity Ordered: Up as tolerated/PT Transfer Assistance: 1-person Toileting:Assist Isolation: No Oxygen: 3 L/min Finger Sticks: NA Vital Signs from Previous Shift: T:98.2f P:84 R:18 BP:129/83 Height: 6’1” Weight:232lbs. BMI:30.6 IV Site: none IV Fluids: none Last 24 hrs intake: na Output: na Patient Introduction (2-3 sentences):RM is a a 68 year old male. A former Los Angeles police sergeant (25 yrs), and most recently a Redi-Mix concrete driver, RM is a real class act. He is facing the fact that he “might not live as long as he previously thought”. But he is accepting his condition rather than wallowing in pity, and is grateful to have some relief from his chronic pain. He experiences PLP (phantom limb pain). He previously had a total left knee arthroplasty that his...
Words: 2041 - Pages: 9
...RMIT International University Vietnam Subject Code: | BUSM3311 | Subject Name: | International Business | Location & Campus (SGS or HN) where you study: | RMIT Vietnam | Title of Assignment: | Final Report (#2 Assignment) | Student name: | Vu Tran Hoang Anh | Student Number: | S3343719 | Teachers Name: | Dennis Tan | Group Number: | #2 | Assignment due date: | 19.08.2013 | Date of Submission: | | Number of pages including this one: | 19 | Word Count: | 2,697 (Included picture/chart in-text citations) | Bachelor of Commerce Program Assignment Cover Page BUSM3311: International Business Name: Vu Tran Hoang Anh | Student ID: s3343719 | SABECO | BUSINESS REPORT | Contents BACKGROUND OF COMPANY 2 AUSTRALIAN MARKET BACKGROUND 4 Market overview 4 Market opportunity 7 COMPETITORS 8 BUSINESS MODEL CONSIDERATION 9 International Joint Venture (IJV) 9 Exporting 10 Wholly Owned Subsidiaries (WOS) 10 PEST ANALYSIS 11 Political 11 Economics 11 Social 12 Technology 13 CRITICAL RISK 14 CONCLUSION 14 REFERENCE LIST 15 BACKGROUND OF COMPANY Saigon Beer Alcohol and Beverage Corporation (SABECO) has a developing history going along with the raise of the brand Saigon Beer. SABECO was officially established in 2003 and the head office is located in 06 Hai Ba Trung Street, District 1, Ho Chi Minh City. Before officially getting in with the current name of SABECO, company had been through several stages of developing...
Words: 3647 - Pages: 15
...of illicit drugs * Use that is harmful and puts the user at risk * Have been used interchangeably by the media * Alcohol use in that context * Social drinking * 1-2 drinks in a day, in any one social occasion * Problem drinking * 3-4 drinks a day * Alcohol abuse * 6-24 drinks a day * What is a drug?: Defining the term * 3 categories: Illegality, Medical utility, Psychoactivity * Medical utility * Used to treat or heal the mind or body * Medicalization: prescription of currently illegal substances for medical purposes * Marijuana in 14 states * Heroin in some countries * Not all substances have medical utility * Categorization by government * Schedule I: no medical utility * Completely illegal with exception of research * Tightest control on availability * Cocaine, meth * Schedule II: some medical utility * High potential for abuse * Tight control on distribution * Heroin, morphine...
Words: 3491 - Pages: 14
...GCC Pharmaceutical Industry March 31, 2013 Alpen Capital was awarded the “Best Research House” at the Banker Middle East Industry Awards 2011 GCC Pharmaceutical Sector | March 31, 2013 Page | 2 Table of Contents 1. 1.1. 1.2. 1.3. 1.4. EXECUTIVE SUMMARY............................................................................ 6 Scope of the Report .................................................................................. 6 Key Growth Drivers .................................................................................. 6 Key Challenges ........................................................................................ 6 Trends .................................................................................................... 7 2. 2.1 2.2 2.3 2.4 2.5 2.6 2.7 GCC PHARMACEUTICAL INDUSTRY OVERVIEW ...................................... 8 GCC Pharmaceutical Market Overview ............................................................. 8 The UAE Pharmaceutical Market .................................................................... 11 The Saudi Arabian Pharmaceutical Market ...................................................... 13 The Kuwaiti Pharmaceutical Market ............................................................... 15 The Qatari Pharmaceutical Market ................................................................. 16 The Bahraini Pharmaceutical Market .............................................................. 17 The...
Words: 27542 - Pages: 111
...CFR - Code of Federal Regulations Title 21 PART 211 | CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS | Subpart B--Organization and Personnel | Sec. 211.22 Responsibilities of quality control unit. | (a) There shall be a quality control unit that shall have the responsibility and authority to approve or reject all components, drug product containers, closures, in-process materials, packaging material, labeling, and drug products, and the authority to review production records to assure that no errors have occurred or, if errors have occurred, that they have been fully investigated. The quality control unit shall be responsible for approving or rejecting drug products manufactured, processed, packed, or held under contract by another company.(b) Adequate laboratory facilities for the testing and approval (or rejection) of components, drug product containers, closures, packaging materials, in-process materials, and drug products shall be available to the quality control unit.(c) The quality control unit shall have the responsibility for approving or rejecting all procedures or specifications impacting on the identity, strength, quality, and purity of the drug product.(d) The responsibilities and procedures applicable to the quality control unit shall be in writing; such written procedures shall be followed. | | Sec. 211.25 Personnel qualifications. | (a) Each person engaged in the manufacture, processing, packing, or holding of a drug product...
Words: 7937 - Pages: 32
...PFIZER’S POWER: Pfizer is one of the largest pharmaceutical companies in the world. Their enormous size and well-know products allow Pfizer to control much of the pharmaceutical industry. They base their company on research throughout the world in order to discover and expand new products. Pfizer’s products can increase the quality of life in living with a medical disorder or actually cure the sickness. The company believes it has the tools to lead the way into the next generation of the industry. Growth and pertinent resources will allow Pfizer to bring consumers the opportunity of better health and well-being. They influence health in over 150 countries and strive to enhance the health of humans in underdeveloped countries. Pfizer seeks to achieve these goals by specializing into four separate groups: Pharmaceuticals group, Consumer Healthcare, Global Research and Development and Animal Health Group. (www.pfizer.com) GROUPS: | FUNCTION: | Pharmaceutical | Produce and market pharmaceutical products | Consumer Healthcare | Produce goods to meet consumer demands including both over-the-counter and generics | Global R&D | Scientists research and produce innovative drugs. | Animal Health | Develop and market drugs to help improve the health of animals | PFIZER’S FOUR GROUPS: 1. Pharmaceutical Group: The Pfizer Pharmaceutical Group produces five of the world’s top-selling medicines, and nine are #1 in their therapeutic class in the U.S. market. Eight...
Words: 6215 - Pages: 25